These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24671413)

  • 1. Parameters that affect macromolecular self-assembly of prion protein.
    Kim SG; Lee HM; Ryou C
    Protein J; 2014 Jun; 33(3):243-52. PubMed ID: 24671413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation and amyloid fibril formation of the prion protein is accelerated in the presence of glycogen.
    Panza G; Stöhr J; Birkmann E; Riesner D; Willbold D; Baba O; Terashima T; Dumpitak C
    Rejuvenation Res; 2008 Apr; 11(2):365-9. PubMed ID: 18341429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
    Kim DH; Lee HM; Ryou C
    J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
    Baskakov IV; Bocharova OV
    Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
    Ladner-Keay CL; Griffith BJ; Wishart DS
    PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal domain of prion protein directs its oligomeric association.
    Trevitt CR; Hosszu LL; Batchelor M; Panico S; Terry C; Nicoll AJ; Risse E; Taylor WA; Sandberg MK; Al-Doujaily H; Linehan JM; Saibil HR; Scott DJ; Collinge J; Waltho JP; Clarke AR
    J Biol Chem; 2014 Sep; 289(37):25497-508. PubMed ID: 25074940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathway complexity of prion protein assembly into amyloid.
    Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
    J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitro.
    Panza G; Luers L; Stöhr J; Nagel-Steger L; Weiss J; Riesner D; Willbold D; Birkmann E
    PLoS One; 2010 Dec; 5(12):e14283. PubMed ID: 21151607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion detection by an amyloid seeding assay.
    Colby DW; Zhang Q; Wang S; Groth D; Legname G; Riesner D; Prusiner SB
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20914-9. PubMed ID: 18096717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated forms of the prion protein PrP demonstrate the need for complexity in prion structure.
    Wan W; Stöhr J; Kendall A; Stubbs G
    Prion; 2015; 9(5):333-8. PubMed ID: 26325658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance.
    Tycko R; Savtchenko R; Ostapchenko VG; Makarava N; Baskakov IV
    Biochemistry; 2010 Nov; 49(44):9488-97. PubMed ID: 20925423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.
    Tahiri-Alaoui A; James W
    Protein Sci; 2005 Apr; 14(4):942-7. PubMed ID: 15741327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.
    Rouget R; Sharma G; LeBlanc AC
    J Biol Chem; 2015 Feb; 290(9):5759-71. PubMed ID: 25572400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid core formed of full-length recombinant mouse prion protein involves sequence 127-143 but not sequence 107-126.
    Chatterjee B; Lee CY; Lin C; Chen EH; Huang CL; Yang CC; Chen RP
    PLoS One; 2013; 8(7):e67967. PubMed ID: 23844138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrillization of recombinant bovine prion protein (rec-PrP) in vitro.
    Grigoriev VB; Kalnov SL; Pokidyshev AN; Tsibezov VV; Balandina MV; Gibadulin RA; Verkhovsky OA; Klimenko SM
    Dokl Biochem Biophys; 2008; 420():112-4. PubMed ID: 18680904
    [No Abstract]   [Full Text] [Related]  

  • 20. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.